Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital

Chest

Volumn 135, Issue 3, 2009, Pages 633-640

  Shindo, Yuichiro ^a   Sato, Shinji ^b   Maruyama, Eiichi ^b   Ohashi, Takamasa ^b   Ogawa, Masahiro ^b   Hashimoto, Naozumi ^a   Imaizumi, Kazuyoshi ^a   Sato, Tosiya ^c   Hasegawa, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Handa City Hospital   (Japan)

^c KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Antibiotics; Drug resistance; Mortality; Pathogens; Severity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL PATIENT; HUMAN; JAPAN; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 62149134893     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1357     Document Type: Article

References (33)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
2. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(suppl):S27-S72
3. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998; 105:319-330
4. Marrie TJ. Pneumonia in the long-term-care facility. Infect Control Hosp Epidemiol 2002; 23:159-164
5. Furman CD, Rayner AV, Tobin EP. Pneumonia in older residents of long-term care facilities. Am Fam Physician 2004; 70:1495-1500
6. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society; the Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31:383-421
7. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405-1433
8. Committee for the Japanese Respiratory Society Guidelines for the Management of Respiratory Infections. Antibacterial therapy of hospital-acquired pneumonia. Respirology 2004; 9(suppl):S16-S24
9. Committee for the Japanese Respiratory Society Guidelines for the Management of Respiratory Infections. Appendix I: nursing-home acquired pneumonia. Respirology 2004; 9(suppl):S51-S55
10. British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults: 2004 Update. Available at: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/ Guidelines/MACAPrevisedApr04.pdf. Accessed October 22, 2008
11. Mylotte JM. Nursing home-acquired pneumonia: update on treatment options. Drugs Aging 2006; 23:377-390
12. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001; 18:362-368
13. Carratalà J, Garcia-Vidal C. What is healthcare-associated pneumonia and how is it managed? Curr Opin Infect Dis 2008; 21:168-173
14. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-3862
15. Carratalà J, Mykietiuk A, Fernandez-Sabe N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167:1393-1399
16. Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51:3568-3573
17. Shindo Y, Sato S, Maruyama E, et al. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 2008; 13:731-735
18. Roson B, Carratalà J, Fernandez-Sabe N, et al. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004; 164:502-508
19. Ishida T, Hashimoto T, Arita M, et al. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 1998; 114:1588-1593
20. Miyashita N, Ouchi K, Kawasaki K, et al. Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae. Respirology 2008; 13:427-431
21. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003; document M7-A6; supplemental tables M100-S13 (M7)
22. Fukuoka Y, Ikeda Y, Yamashiro Y, et al. In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrob Agents Chemother 1993; 37:384-392
23. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
24. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14:933-951
25. Committee for the Japanese Respiratory Society Guidelines for the Management of Respiratory Infections. The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults. Respirology 2006; 11(suppl): S1-S133
26. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-382
27. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
28. Craven DE. What is healthcare-associated pneumonia, and how should it be treated? Curr Opin Infect Dis 2006; 19:153-160
29. Zilberberg MD, Shorr AF, Micek ST, et al. Antimicrobial therapy escalation and hospital mortality among patients with HCAP: a single center experience. Available at: http://www.chestjournal.org/papbyrecent.dtl. Accessed on October 22, 2008
30. Abrahamian FM, Deblieux PM, Emerman CL, et al. Health care-associated pneumonia: identification and initial management in the ED. Am J Emerg Med 2008; 26:1-11
31. Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes; proceedings of the HCAP Summit. Clin Infect Dis 2008; 46(suppl):S296-S334
32. Verghese A, Berk SL. Bacterial pneumonia in the elderly. Medicine (Baltimore) 1983; 62:271-285
33. Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury: incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999; 159:188-198